Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of trinitroglycerin and adenosine as provocative agents for head-up tilt test in patients with unexplained syncope: a semi-crossover randomized clinical trial with prospective follow-up.
Tajdini M, Aminorroaya A, Rahimi B, Mortazavi SH, Vasheghani Farahani A, Sadeghian S, Easapour Moghadam M, Soltani D, Bozorgi A. Tajdini M, et al. Among authors: sadeghian s. J Interv Card Electrophysiol. 2021 Jan;60(1):31-39. doi: 10.1007/s10840-019-00652-6. Epub 2020 Jan 7. J Interv Card Electrophysiol. 2021. PMID: 31907833 Clinical Trial.
The impact of a dedicated coronavirus disease 2019 primary angioplasty protocol on time components related to ST‑segment elevation myocardial infarction management in a 24/7 primary percutaneous coronary intervention-capable hospital.
Salarifar M, Ghavami M, Poorhosseini H, Masoudkabir F, Jenab Y, Amirzadegan A, Alidoosti M, Aghajani H, Bozorgi A, Hosseini K, Lotfi-Tokaldany M, Mortazavi SH, Aein A, Ahmadian T, Sadeghian S. Salarifar M, et al. Among authors: sadeghian s. Kardiol Pol. 2020 Dec 23;78(12):1227-1234. doi: 10.33963/KP.15607. Epub 2020 Sep 21. Kardiol Pol. 2020. PMID: 32955819 Free article.
Comparison of Outcomes with Midodrine and Fludrocortisone for Objective Recurrence in Treating Syncope (COMFORTS trial): Rationale and design for a multi-center randomized controlled trial.
Aminorroaya A, Tavolinejad H, Sadeghian S, Jalali A, Alaeddini F, Emkanjoo Z, Mollazadeh R, Bozorgi A, Oraii S, Kiarsi M, Shahabi J, Akbarzadeh MA, Rahimi B, Joharimoghadam A, Mohsenizade A, Mohammadi R, Oraii A, Ariannejad H, Apakuppakul S, Ngarmukos T, Tajdini M. Aminorroaya A, et al. Among authors: sadeghian s. Am Heart J. 2021 Jul;237:5-12. doi: 10.1016/j.ahj.2021.03.002. Epub 2021 Mar 6. Am Heart J. 2021. PMID: 33689731 Clinical Trial.
225 results